• MBBCh (Wits)

  • FCPath (Anat Path)

Journey with Lancet Laboratories

Dr Beavon joined Lancet Laboratories in 2001 from the South African Institute for Medical Research. He became a partner in 2008 and his interests include Gynaecological and Pancreaticobiliary pathology and Cytology. Dr Beavon served on the Johannesburg General Hospital Gynaecological Oncology Group for several years and he is a member of the East Rand Multi Speciality Oncology Board.